There were no significant differences in mean fluorescence intensity (MFI) of mBAFF on both granulocytes and monocytes (Figure 1B and 1C, respectively), in the fraction of B cells with intracellular IL-1β or IL-6 expression (Figure 2B and 2C, respectively), and the numbers of CD80-positive and CD86-positive activated B cells among the three mutational groups of ET patients (Figure 3B and 3C, respectively). This evidence concerns the gene CD80 and essential thrombocythemia.